AFFY - Affymax, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Affymax, Inc.

630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
650-812-8700
http://www.affymax.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees2

Key Executives

NameTitlePayExercisedAge
Mr. Mark G. ThompsonChief Financial Officer and Sec.97.49kN/A55
Mr. Jonathan M. Couchman CFAChief Exec. Officer, Pres and DirectorN/AN/A47
Dr. Tracy J. Dunn Ph.D., J.D.VP of Intellectual Property & Legal AffairsN/AN/A54
Ms. Kay SlocumSr. VP of HRN/AN/A70
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Corporate Governance

Affymax, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.